• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先是受害者,后成攻击者:肠道微生物群如何驱动膳食乳化剂的促炎作用?

First victim, later aggressor: How the intestinal microbiota drives the pro-inflammatory effects of dietary emulsifiers?

作者信息

Viennois Emilie, Chassaing Benoit

机构信息

a Institute for Biomedical Sciences, Georgia State University , Atlanta , GA.

b Neuroscience Institute, Georgia State University , Atlanta , GA.

出版信息

Gut Microbes. 2018 Feb 13;9(3):1-4. doi: 10.1080/19490976.2017.1421885.

DOI:10.1080/19490976.2017.1421885
PMID:29437527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6219590/
Abstract

The intestinal tract is inhabited by a large and diverse community of bacteria, collectively referred to as the gut microbiota. Composed of 500-1000 distinct species, the intestinal microbiota plays an important role in immunity and metabolism. However, alterations in its composition are associated with a variety of inflammatory diseases including obesity, diabetes, and inflammatory bowel disease (IBD). Among many other factors, our diet impacts microbiota composition and function, in either beneficial or detrimental ways. In this addendum, we will discuss our recent findings on how dietary emulsifying agents can directly and detrimentally impact the microbiota, leading to inflammatory diseases and cancer.

摘要

肠道中栖息着大量种类多样的细菌群落,统称为肠道微生物群。肠道微生物群由500 - 1000个不同的物种组成,在免疫和代谢中发挥着重要作用。然而,其组成的改变与多种炎症性疾病有关,包括肥胖、糖尿病和炎症性肠病(IBD)。在许多其他因素中,我们的饮食以有益或有害的方式影响微生物群的组成和功能。在本附录中,我们将讨论我们最近关于膳食乳化剂如何直接且有害地影响微生物群,从而导致炎症性疾病和癌症的研究发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8612/6219590/d25bd2fbdecc/kgmi-09-03-1421885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8612/6219590/d25bd2fbdecc/kgmi-09-03-1421885-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8612/6219590/d25bd2fbdecc/kgmi-09-03-1421885-g001.jpg

相似文献

1
First victim, later aggressor: How the intestinal microbiota drives the pro-inflammatory effects of dietary emulsifiers?先是受害者,后成攻击者:肠道微生物群如何驱动膳食乳化剂的促炎作用?
Gut Microbes. 2018 Feb 13;9(3):1-4. doi: 10.1080/19490976.2017.1421885.
2
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.饮食乳化剂会影响小鼠肠道微生物群,促进结肠炎和代谢综合征。
Nature. 2015 Mar 5;519(7541):92-6. doi: 10.1038/nature14232. Epub 2015 Feb 25.
3
Direct impact of commonly used dietary emulsifiers on human gut microbiota.常用膳食乳化剂对人体肠道微生物群的直接影响。
Microbiome. 2021 Mar 22;9(1):66. doi: 10.1186/s40168-020-00996-6.
4
Insights on the impact of diet-mediated microbiota alterations on immunity and diseases.饮食介导的微生物组改变对免疫和疾病影响的研究进展
Am J Transplant. 2018 Mar;18(3):550-555. doi: 10.1111/ajt.14477. Epub 2017 Sep 23.
5
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
6
Gut microbiota, low-grade inflammation, and metabolic syndrome.肠道微生物群、低度炎症与代谢综合征
Toxicol Pathol. 2014 Jan;42(1):49-53. doi: 10.1177/0192623313508481. Epub 2013 Nov 27.
7
Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation.膳食乳化剂可直接改变人体微生物群组成并在体外增强肠道炎症,从而影响基因表达。
Gut. 2017 Aug;66(8):1414-1427. doi: 10.1136/gutjnl-2016-313099. Epub 2017 Mar 21.
8
counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism.对抗膳食乳化剂对微生物组和宿主代谢的有害影响。
Gut. 2023 May;72(5):906-917. doi: 10.1136/gutjnl-2021-326835. Epub 2023 Jan 16.
9
Food Additive Emulsifiers and Their Impact on Gut Microbiome, Permeability, and Inflammation: Mechanistic Insights in Inflammatory Bowel Disease.食品添加剂乳化剂及其对肠道微生物组、通透性和炎症的影响:炎症性肠病的机制见解。
J Crohns Colitis. 2021 Jun 22;15(6):1068-1079. doi: 10.1093/ecco-jcc/jjaa254.
10
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化:结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.

引用本文的文献

1
Gut microbiota interacting with vitamin D but not anandamide might contribute to the pathogenesis of preeclampsia: a preliminary study.肠道微生物群与维生素D而非花生四烯乙醇胺相互作用可能与子痫前期的发病机制有关:一项初步研究。
Front Cell Infect Microbiol. 2025 Feb 5;14:1469054. doi: 10.3389/fcimb.2024.1469054. eCollection 2024.
2
An Adverse Outcome Pathway for food nanomaterial-induced intestinal barrier disruption.食品纳米材料诱导肠道屏障破坏的不良结局途径。
Front Toxicol. 2024 Dec 24;6:1474397. doi: 10.3389/ftox.2024.1474397. eCollection 2024.
3
Epithelial barrier dysfunction and associated diseases in companion animals: Differences and similarities between humans and animals and research needs.

本文引用的文献

1
Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health.纤维介导的肠道微生物群营养可通过恢复 IL-22 介导的结肠健康来预防饮食诱导的肥胖。
Cell Host Microbe. 2018 Jan 10;23(1):41-53.e4. doi: 10.1016/j.chom.2017.11.003. Epub 2017 Dec 21.
2
Regulation of inflammation by microbiota interactions with the host.微生物群与宿主相互作用对炎症的调节。
Nat Immunol. 2017 Jul 19;18(8):851-860. doi: 10.1038/ni.3780.
3
Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation.
伴侣动物的上皮屏障功能障碍及相关疾病:人与动物的异同及研究需求
Allergy. 2024 Dec;79(12):3238-3268. doi: 10.1111/all.16343. Epub 2024 Oct 17.
4
Intestinal permeability disturbances: causes, diseases and therapy.肠通透性紊乱:病因、疾病与治疗。
Clin Exp Med. 2024 Sep 28;24(1):232. doi: 10.1007/s10238-024-01496-9.
5
Ultra-processed foods and food additives in gut health and disease.超加工食品和食品添加剂与肠道健康和疾病。
Nat Rev Gastroenterol Hepatol. 2024 Jun;21(6):406-427. doi: 10.1038/s41575-024-00893-5. Epub 2024 Feb 22.
6
Involvement and repair of epithelial barrier dysfunction in allergic diseases.变应性疾病中上皮屏障功能障碍的参与和修复。
Front Immunol. 2024 Feb 1;15:1348272. doi: 10.3389/fimmu.2024.1348272. eCollection 2024.
7
Research progress on the correlation between gut microbiota and preeclampsia: microbiome changes, mechanisms and treatments.关于肠道微生物群与子痫前期相关性的研究进展:微生物组变化、机制和治疗。
Front Cell Infect Microbiol. 2023 Oct 31;13:1256940. doi: 10.3389/fcimb.2023.1256940. eCollection 2023.
8
Exploring Plasma-Level Gut Microbiota Mediators and Pro-Inflammatory Markers in Pregnant Women with Short Cervix and Gestational Diabetes Mellitus.探讨短宫颈伴妊娠期糖尿病孕妇的血浆水平肠道微生物群介导物和促炎标志物。
Int J Mol Sci. 2023 Sep 4;24(17):13653. doi: 10.3390/ijms241713653.
9
Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration.小肠与结肠的生态与生理学:在益生菌给药中的意义。
Cell Rep Med. 2023 Sep 19;4(9):101190. doi: 10.1016/j.xcrm.2023.101190. Epub 2023 Sep 7.
10
Ultraprocessed Foods and Obesity Risk: A Critical Review of Reported Mechanisms.超加工食品与肥胖风险:对报告机制的批判性综述。
Adv Nutr. 2023 Jul;14(4):718-738. doi: 10.1016/j.advnut.2023.04.006. Epub 2023 Apr 18.
膳食乳化剂可直接改变人体微生物群组成并在体外增强肠道炎症,从而影响基因表达。
Gut. 2017 Aug;66(8):1414-1427. doi: 10.1136/gutjnl-2016-313099. Epub 2017 Mar 21.
4
Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.膳食乳化剂诱导的低度炎症促进结肠癌发生。
Cancer Res. 2017 Jan 1;77(1):27-40. doi: 10.1158/0008-5472.CAN-16-1359. Epub 2016 Nov 7.
5
Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model.在体外肠道模型中研究了产丁酸的普氏丁酸球菌25-3T治疗反应的个体差异。
FEMS Microbiol Ecol. 2015 Jun;91(6). doi: 10.1093/femsec/fiv054. Epub 2015 May 20.
6
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.饮食乳化剂会影响小鼠肠道微生物群,促进结肠炎和代谢综合征。
Nature. 2015 Mar 5;519(7541):92-6. doi: 10.1038/nature14232. Epub 2015 Feb 25.
7
Artificial sweeteners induce glucose intolerance by altering the gut microbiota.人工甜味剂通过改变肠道微生物群诱导葡萄糖不耐受。
Nature. 2014 Oct 9;514(7521):181-6. doi: 10.1038/nature13793. Epub 2014 Sep 17.
8
Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences.在关键发育窗口期改变肠道微生物群会产生持久的代谢后果。
Cell. 2014 Aug 14;158(4):705-721. doi: 10.1016/j.cell.2014.05.052.
9
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity.阿克曼氏菌与肠道上皮细胞的串扰控制饮食诱导的肥胖。
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71. doi: 10.1073/pnas.1219451110. Epub 2013 May 13.
10
Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's disease.假说:乳化剂摄入量增加是导致克罗恩病发病率上升的原因。
J Crohns Colitis. 2013 May;7(4):338-41. doi: 10.1016/j.crohns.2013.01.004. Epub 2013 Jan 27.